Pancreas-on-a-chip technology to aid in diabetes research
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
List view / Grid view
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Researchers have developed a new AI system which was able to discover and then successfully test several new compounds within 46 days.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
Claus Bendtsen at AstraZeneca reveals how AI can be used to improve our understanding of disease, to help identify the causes of conditions and aid in drug discovery.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
CD4+ T-cells play a central role in directing adaptive immune responses against invading microbial pathogens.
Sartorius debuts their new product, the Intellicyt iQue3, at this year's CYTO® conference and exhibition.
Mosaic Sample Management is Titian Software’s comprehensive, customisable, modular software product to control and monitor all aspects of sample storage, preparation and delivery.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
New method for computational mass spectrometry will speed up the discovery of natural products that could be used in medicines...
Data drives drug discovery, yet it continues to be among the biggest challenges faced by the industry.1 Experiments are often not repeatable and data interpretation is subject to the biases and limitations of human beings.
In this In-Depth Focus: AI-driven automated chemistry as a tool to accelerate drug discovery, and a look at network-driven drug discovery